Biotechnology – Study Notes for D.Pharm Admission
(Biology – 1st Year)
1. What is Biotechnology?
A branch of science that uses living organisms, cells, or sub‑cellular components to create or modify products and processes for specific purposes. In pharmacy it powers drug discovery, vaccine production, diagnostics, and therapeutic biologics.
Simple analogy: Think of biotechnology as a molecular tailor – it stitches DNA, proteins, and cells together to create new materials (drugs, vaccines, etc.).
2. Key Points
| Category | Details |
|---|---|
| Origins | 1940s–1950s – recombinant DNA, PCR, cloning. |
| Core Tools | - Recombinant DNA technology (cloning, plasmids) - PCR & qPCR (DNA amplification) - CRISPR‑Cas (gene editing) - Cell culture & bioreactors (protein production) - Microbial fermentation |
| Types of Biotechnology | 1. Conventional – selective breeding, mutation breeding. 2. Modern (Genetic/Genomic) – DNA manipulation, gene therapy. 3. Cellular – cell‑based therapies, stem cells. 4. Microbiological – industrial enzymes, antibiotics. |
| Pharmaceutical Relevance | - Biologics (monoclonal antibodies, cytokines, vaccines). - Recombinant proteins (insulin, growth factors). - Gene therapy (e.g., hemophilia). - Diagnostic kits (PCR‑based tests). |
| Regulatory & Ethical Issues | - GMO safety (environmental, human health). - Intellectual property (patents on biologics). - Ethics (gene editing, cloning). |
| Future Trends | - Personalized medicine via genomics. - Synthetic biology (designing new biological systems). - CRISPR therapeutics for genetic disorders. |
3. Worked Example – Production of Recombinant Human Insulin
| Step | Description |
|---|---|
| 1. Gene Identification | The INS gene (human insulin) is isolated from a cDNA library. |
| 2. Cloning | Insert the INS gene into a plasmid vector (e.g., pET‑28a). The vector carries a promoter (T7) and antibiotic resistance marker. |
| 3. Transformation | Introduce the plasmid into E. coli BL21(DE3) cells via heat shock. |
| 4. Expression | Add IPTG to induce the T7 promoter. The bacteria synthesize pre‑proinsulin. |
| 5. Purification | Harvest cells → lyse → isolate the protein using affinity chromatography (His‑tag). |
| 6. Refolding & C‑peptide Removal | The recombinant peptide is refolded to form the insulin structure and cleaved to remove the C‑peptide. |
| 7. Quality Control | Verify purity (>98 %) via HPLC and mass spectrometry. |
| 8. Formulation | Final product formulated into a sterile injectable solution. |
Key Takeaway: Recombinant DNA technology allows production of a safe, cost‑effective human hormone in bacterial systems, bypassing the need for animal extraction.
4. Quick Revision Summary
- Biotechnology = use of living systems to make or modify products.
- Main Tools: recombinant DNA, PCR, CRISPR, cell culture, fermentation.
- Types: conventional, genetic, cellular, microbiological.
- Pharma Use: biologics (monoclonal antibodies, vaccines), recombinant proteins (insulin), gene therapy, diagnostics.
- Regulation: safety, GMOs, IP, ethics.
- Future: personalized medicine, synthetic biology, CRISPR therapeutics.
Remember: In pharmacy, biotechnology is the engine that turns genetic blueprints into clinically useful drugs.
Practice Question
Explain how CRISPR‑Cas9 can be used to develop a therapeutic for sickle cell disease.
Answer Outline
- Identify the point mutation (A→T) in the β‑globin gene.
- Design a guide RNA matching the mutant sequence.
- Deliver Cas9‑gRNA complex + a donor DNA template into hematopoietic stem cells.
- Cas9 induces double‑strand break; HDR uses donor to correct the mutation.
- Transplant corrected cells back → production of normal hemoglobin.
Good luck with your studies! Feel free to revisit these notes before the exam.